![Iraj Ali](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Iraj Ali
Directeur Général chez
ACHILLES THERAPEUTICS PLC
Profil
Iraj Ali is Chief Executive Officer & Director at Achilles Therapeutics Plc since 2018.
Former roles include Chief Executive Officer & Director at Achilles Therapeutics UK Ltd. from 2018 to 2025, Director at NightstaRx Ltd., Director & Investment Partner at Blue Earth Diagnostics Ltd. from 2014 to 2018, Director & Investment Partner at Nightstar Therapeutics Ltd. from 2013 to 2015, Managing Partner at Syncona Ltd. from 2016 to 2018, Partner at Syncona Partners LLP, and Associate & Principal at McKinsey & Company Holdings Ltd. from 2006 to 2012.
Education includes a doctorate from the University of Cambridge and an undergraduate degree from The University of Reading.
Postes actifs de Iraj Ali
| Sociétés | Poste | Début |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Directeur Général | 01/01/2018 |
Anciens postes connus de Iraj Ali
| Sociétés | Poste | Fin |
|---|---|---|
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Directeur Général | 01/03/2025 |
Blue Earth Diagnostics Ltd.
 Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Directeur/Membre du Conseil | 01/12/2018 |
| SYNCONA LIMITED | Corporate Officer/Principal | 01/12/2018 |
| NIGHTSTAR THERAPEUTICS PLC | Directeur/Membre du Conseil | 01/11/2015 |
McKinsey & Company Holdings Ltd.
 McKinsey & Company Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | 01/09/2012 |
Formation de Iraj Ali
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Health Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
McKinsey & Company Holdings Ltd.
McKinsey & Company Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
